These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 5646852)

  • 1. Spleen colony studies of leukemia L1210. 3. Differential sensitivities of normal hematopoietic and resistant L1210 colony-forming cells to 6-mercaptopurine (NSC-755).
    Wodinsky I; Swiniarski J; Kensler CJ
    Cancer Chemother Rep; 1968 Feb; 52(2):251-5. PubMed ID: 5646852
    [No Abstract]   [Full Text] [Related]  

  • 2. Cain's quinolinium (NSC 176319): protection of murine L1210 leukemia cells and bone marrow progenitor cells against mechlorethamine cytotoxicity and its application to combination chemotherapy.
    Naujokaitis SA
    Res Commun Chem Pathol Pharmacol; 1981 Oct; 34(1):97-104. PubMed ID: 7313308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy of leukemia L1210 by 6-mercaptopurine (NSC-755) in combination with 6-methylthiopurine ribonucleoside (NSC-40774).
    Schabel FM; Laster WR; Skipper HE
    Cancer Chemother Rep; 1967 Jun; 51(3):111-24. PubMed ID: 6043734
    [No Abstract]   [Full Text] [Related]  

  • 4. Spleen colony studies of leukemia L1210. IV. Sensitivities of L1210 and L1210/6-MP to triazenoimidazolecarboxamides--a preliminary report.
    Wodinsky I; Swiniarski J; Kensler CJ
    Cancer Chemother Rep; 1968 Apr; 52(3):393-8. PubMed ID: 5670721
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined therapy of L1210 leukemia with Damvar and cytostatics.
    Pujman V; Cernochová S
    Neoplasma; 1979; 26(5):521-3. PubMed ID: 522924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti leukemia activity (L1210) of 6-mercaptopurine and its metallo complexes in mice.
    Skinner SM; Lewis RW
    Res Commun Chem Pathol Pharmacol; 1977 Jan; 16(1):183-6. PubMed ID: 841179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of drug combination of antitumor activity and myelotoxicity.
    Fujimoto S; Inouye T; Tsukagoshi S
    Gan; 1976 Apr; 67(2):207-14. PubMed ID: 964553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chemotherapy of L1210 leukemia: comparison of 7 drugs given either continuously for 20 days, or in a single massive dose, early or late].
    Mathé G; Schwarzenberg L; Hayat M; Schneider M
    Rev Fr Etud Clin Biol; 1968 Dec; 13(10):951-60. PubMed ID: 5306738
    [No Abstract]   [Full Text] [Related]  

  • 9. Basis of observed resistance of L1210 leukemia in mice: methotrexate, 6-thioguanine, 6-methylmercaptopurine riboside, 6-mercaptopurine, 5-fluorouracil, and 1-beta-D-arabinofuranosylcytosine administered in different combinations.
    Kim K; Blechman WJ; Riddle VG; Pardee AB
    Cancer Res; 1981 Nov; 41(11 Pt 1):4529-34. PubMed ID: 7198006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The return of antimetabolite sensitivity in methotrexate- and 6-mercaptopurine-resistant L1210 murine leukemia by the process of adaptive selection.
    Wallerstein H; Slater LM; Eng B; Calman N
    Cancer Res; 1972 Oct; 32(10):2235-40. PubMed ID: 5080766
    [No Abstract]   [Full Text] [Related]  

  • 11. Reversal of methotrexate inhibition of colony growth of L1210 leukemia cells in semisolid medium.
    Nederbragt H; Uitendaal MP; van der Grint L; Leyva A; Pinedo HM
    Cancer Res; 1981 Mar; 41(3):1193-8. PubMed ID: 6970074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of the antitumor effect of 6-mercaptopurine by vitamin A.
    Akiyama S; Masuda A; Tabuki T; Kuwano M; Komiyama S
    Gan; 1981 Oct; 72(5):742-6. PubMed ID: 7199007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiosensitivity of drug-resistant L1210 leukemia.
    Johnson RE
    Cancer Res; 1967 Feb; 27(2):251-4. PubMed ID: 6018559
    [No Abstract]   [Full Text] [Related]  

  • 14. In vivo study of acute hematotoxicity of three nitrosoureas, chlorozotocin (chloro-2-ethyl)-ribofuranosyl-3-nitrosourea, and (chloro-2-ethyl)-1-ribopyranosyl-3-nitrosourea.
    Mori KJ; Jasmin C; Hayat M; MacDonald JS; Mathé G
    Cancer Res; 1980 Nov; 40(11):4282-6. PubMed ID: 6451285
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclophosphamide. I. Effects of survival and colony-forming cells in BDF1 L-1210-bearing mice.
    Pazdernik TL; Uyeki EM
    J Pharmacol Exp Ther; 1978 Oct; 207(1):255-61. PubMed ID: 702348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fate of amethopterin-resistant mutants in L1210 mouse leukemia populations.
    Hoshino A; Albrecht AM; Hutchison DJ
    Cancer Res; 1966 May; 26(5):974-8. PubMed ID: 5934806
    [No Abstract]   [Full Text] [Related]  

  • 17. Modification of tumor regression by immunologic means.
    Mihich E
    Cancer Res; 1969 Dec; 29(12):2345-50. PubMed ID: 5387264
    [No Abstract]   [Full Text] [Related]  

  • 18. [Elimination of suppressor macrophages in tumor-bearing mice by 6-mercaptopurine and its therapeutic contribution].
    Kataoka T
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):701-5. PubMed ID: 3963841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of combination treatment with 5-azacytidine and cytidine on the life-span and spleen and bone marrow cells of leukemic (L1210) and nonleukemic mice.
    Vadlamudi S; Choudry JN; Waravdekar VS; Kline I; Goldin A
    Cancer Res; 1970 Feb; 30(2):362-9. PubMed ID: 5458970
    [No Abstract]   [Full Text] [Related]  

  • 20. DCMP therapy in acute leukemia--the experimental and clinical study.
    Ogawa M; Hoshino A
    Nihon Ketsueki Gakkai Zasshi; 1974 Jun; 37(3):344-50. PubMed ID: 4479924
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.